Efficacy and Safety of Methotrexate Therapy for Juvenile Rheumatoid Arthritis

Halilova, K. I., Brown, E. E., Morgan, S. L., Jr., S. L. B., Hwang, M. H., Arnett, D. K., & Danila, M. I. (2012). Markers of Treatment Response to Methotrexate in Rheumatoid Arthritis: Where Do We Stand?. International Journal of Rheumatology, 2012(), 367-373. https://doi.org/10.1155/2012/978396
Patanè, M., Ciriaco, M., Chimirri, S., Ursini, F., Naty, S., Grembiale, R. D., Gallelli, L., Sarro, G. D., & Russo, E. (2013). Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis. Advances in Pharmacological Sciences, 2013(), 60-67. https://doi.org/10.1155/2013/313858
iam, P. C. S. (1994). The role of self-efficacy in rheumatoid arthritis patients [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200004111
Huang, Y. F., Lai, C. C., Chou, C. T., Tsai, C. Y., & Chen, W. S. (2016). Rituximab retention rate in rheumatoid arthritis: a single center experience. Formosan Journal of Rheumatology, 30(2), 62-67. https://doi.org/10.6313/FJR.2016.12(01).06
Ogata, A., Hirano, T., Hishitani, Y., & Tanaka, T. (2012). Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, (2012), 27-41. https://doi.org/10.4137/CMAMD.S7371